Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/105190
| Title: | Editorial : Drugging p53 for non-cancer diseases | Authors: | Jiang, F Li, CG Seto, SW |
Issue Date: | 2022 | Source: | Frontiers in pharmacology, 2022, v. 13, 1101742 | Keywords: | Activator Drug discovery Drug target Inhibitor Ligand Non-cancer disease P53 Small molecule |
Publisher: | Frontiers Research Foundation | Journal: | Frontiers in pharmacology | EISSN: | 1663-9812 | DOI: | 10.3389/fphar.2022.1101742 | Rights: | Copyright © 2022 Jiang, Li and Seto. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. The following publication Jiang F, Li C-G and Seto S-W (2022) Editorial: Drugging p53 for non-cancer diseases. Front. Pharmacol. 13:1101742 is available at https://doi.org/10.3389/fphar.2022.1101742. |
| Appears in Collections: | Journal/Magazine Article |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| fphar-13-1101742.pdf | 503.26 kB | Adobe PDF | View/Open |
Access
View full-text via PolyU eLinks 
Page views
11
Citations as of Jul 7, 2024
Downloads
2
Citations as of Jul 7, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.